PLERIXAFOR CAN PREDICTABLY MOBILIZE HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE

被引：0
|
作者：
Tarantolo, S. R. [1 ]
McSweeney, P. A. [2 ]
Micallef, I. N. M. [3 ]
Klein, L. M. [4 ]
Calandra, G. [5 ]
Huebner, D. [5 ]
机构：
[1] Nebraske Methodist Hosp, Omaha, NE USA
[2] Rocky Mt Canc Ctr, Denver, CO USA
[3] Mayo Clin, Rochester, MN USA
[4] Advocate Lutheran Gen Hosp, Niles, IL USA
[5] Genzyme Corp, Cambridge, MA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
91
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Growth factor plus preemptive (‘just-in-time’) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure
    L J Costa
    J Abbas
    K R Hogan
    C Kramer
    K McDonald
    C D Butcher
    A Littleton
    K Shoptaw
    Y Kang
    R K Stuart
    Bone Marrow Transplantation, 2012, 47 : 1403 - 1408
  • [22] Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
    Green, D. J.
    Bensinger, W. I.
    Holmberg, L. A.
    Gooley, T.
    Till, B. G.
    Budde, L. E.
    Pagel, J. M.
    Frayo, S. L.
    Roden, J. E.
    Hedin, L.
    Press, O. W.
    Gopal, A. K.
    BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1330 - 1336
  • [23] COLLECTION AND TRANSPLANTATION OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE
    Grubovic, R. M.
    Alavi, A.
    Schiller, G. J.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S49 - S49
  • [24] Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
    D J Green
    W I Bensinger
    L A Holmberg
    T Gooley
    B G Till
    L E Budde
    J M Pagel
    S L Frayo
    J E Roden
    L Hedin
    O W Press
    A K Gopal
    Bone Marrow Transplantation, 2016, 51 : 1330 - 1336
  • [25] Efficacy of Lenalidomide in Patients with Multiple Myeloma Previously Treated by Melphalan-Prednisone and Thalidomide
    Michel, Jessica
    Revuz, Sabine
    Tardy, Stephanie
    Fouquet, Guillemette
    Roussel, Murielle
    Balasanu, Oana
    Bologna, Serge
    Bonmati, Caroline
    Perrot, Aurore
    Ranta, Dana
    Feugier, Pierre
    Attal, Michel
    Leleu, Xavier
    Facon, Thierry
    Hulin, Cyrille
    BLOOD, 2012, 120 (21)
  • [26] ECONOMIC EVALUATION OF LENALIDOMIDE IN THE MANAGEMENT OF PREVIOUSLY TREATED MULTIPLE MYELOMA (PTMM) PATIENTS IN GREECE
    Fragoulakis, V
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2012, 15 (04) : A104 - A105
  • [27] Reply to 'Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients'
    Kumar, S.
    Gertz, M. A.
    LEUKEMIA, 2008, 22 (06) : 1281 - 1282
  • [28] Reply to ‘Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients’
    S Kumar
    M A Gertz
    Leukemia, 2008, 22 : 1281 - 1282
  • [29] INITIAL MOBILIZATION OF AUTOLOGOUS PERIPHERAL BLOOD STEM CELLS WITH GRANULOCYTE COLONY-STIMULATING FACTOR AND PLERIXAFOR IN PATIENTS WITH MULTIPLE MYELOMA: A PROSPECTIVE COMPARISON IN LENALIDOMIDE- AND NON-LENALIDOMIDE-TREATED PATIENTS
    Anwer, F.
    Green, M. R.
    Yeager, A. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S201 - S201
  • [30] Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma
    Takakuwa, Teruhito
    Ohta, Kensuke
    Nakatani, Eiji
    Ito, Tomoki
    Kaneko, Hitomi
    Fuchida, Shin-Ichi
    Shimura, Yuji
    Yagi, Hideo
    Shibayama, Hirohiko
    Kanda, Junya
    Uchiyama, Hitoji
    Kosugi, Satoru
    Tanaka, Hirokazu
    Kawata, Eri
    Uoshima, Nobuhiko
    Ishikawa, Jun
    Shibano, Masaru
    Karasuno, Takahiro
    Shindo, Maki
    Shimizu, Yoshifumi
    Imada, Kazunori
    Kanakura, Yuzuru
    Kuroda, Junya
    Hino, Masayuki
    Nomura, Shosaku
    Takaori-Kondo, Akifumi
    Shimazaki, Chihiro
    Matsumura, Itaru
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (03) : 349 - 357
12345